生命科学资讯

Thermo Fisher Scientific (TMO) Valuation Check After Recent Share Price Momentum - Yahoo Finance

With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera

CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations

Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive

R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific's trio of R&D 100 wins in 2025 - R&D World

THERMO FISHER SCIENTIFIC Q4 2025 Earnings Preview: Recent $TMO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga

Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb

Hospitals could earn more for buying US-made drugs, CMS proposes

Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets

TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio

Cardiff execs depart as company drops mixed Phase 2 data

UnitedHealth projects lower revenue in 2026 as it resets its business

Former Cytodyn CEO faces prison time, millions in restitution

Appointments and advancements for Jan. 27, 2026

Financings for Jan. 27, 2026

In the clinic for Jan. 27, 2026

Other news to note for Jan. 27, 2026

Regulatory actions for Jan. 27, 2026

FDA lifts hold on an Intellia CRISPR drug trial